MYC oncogenes and human neoplastic disease

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The MYC family of oncoproteins, including c-MYC, N-MYC, and L-MYC, are implicated in the pathogenesis of numerous human cancers.
• Empirical evidence supports the significant role of MYC oncoproteins in the development and progression of various neoplastic diseases.

Purpose of the Study:

• To review and summarize the distinct in vivo roles of c-MYC, N-MYC, and L-MYC oncoproteins.
• To correlate the deregulated expression of specific MYC genes with particular human malignancies.
• To identify unresolved questions for future basic and clinical research regarding MYC gene involvement in cancer.

Main Methods:

• Review of data primarily from non-clinical studies on MYC oncoprotein function.
• Analysis of evidence linking specific MYC genes to distinct neoplastic diseases.
• Examination of studies utilizing primary tumor material to confirm MYC involvement.

Main Results:

• MYC oncoproteins (c-MYC, N-MYC, L-MYC) exhibit distinct functional roles in vivo.
• The deregulated expression of each MYC gene is specifically associated with certain human cancers.
• MYC genes are not interchangeable; their aberrant functional consequences differ.

Conclusions:

• The distinct roles of MYC oncoproteins explain their specific associations with different human malignancies.
• Further investigation is warranted to address unresolved questions regarding MYC gene involvement in cancer causation and progression.
• Confirmatory evidence from primary tumor studies supports the role of MYC members in specific cancers.